A2 Biotherapeutics Inc

A2 Biotherapeutics is a clinical-stage cell therapy company developing logic-gated T-cell therapies for solid tumors using its proprietary Tmod platform, which pairs an activator and a blocker receptor to selectively kill tumor cells while sparing normal tissue. Lead programs target metastatic colorectal cancer and cervical cancer.